Status:
ACTIVE_NOT_RECRUITING
Tumor Microenvironment
Lead Sponsor:
University Hospital Heidelberg
Conditions:
Lung Adenocarcinoma
Eligibility:
All Genders
18-90 years
Brief Summary
Cancer immunotherapy has the great potential to achieve long-term survival in patients with a solid malignancy. However, the beneficial effect of cancer immunotherapy is seen in only a minority of pat...
Eligibility Criteria
Inclusion
- Lung adenocarcinoma
- Tumor stage IB and II
- With or without adjuvant therapy
- Complete surgical resection (R0)
- No distant metastasis at the time of surgery (M0)
Exclusion
- • Second cancer within 5 years
Key Trial Info
Start Date :
February 1 2016
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2026
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT05982574
Start Date
February 1 2016
End Date
December 1 2026
Last Update
May 8 2024
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.